Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
Saved in:
| Title: | Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL). |
|---|---|
| Authors: | Malfona F; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Testi AM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Moleti ML; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Petrucci L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Leccisotti L; Nuclear Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome., Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Di Rocco A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 483-486. Date of Electronic Publication: 2021 Oct 06. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
